# Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir

> **NCT03818308** · PHASE2 · COMPLETED · sponsor: **Hannover Medical School** · enrollment: 20 (actual)

## Conditions studied

- Hepatitis C
- Acute Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir and Velpatasvir

## Key facts

- **NCT ID:** NCT03818308
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-28
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-07-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03818308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03818308, "Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03818308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*